Recall Record

Richmond, VA, United States

Mckesson Medical-Surgical Inc. Corporate Office recalls

15 recalls recorded since 2018, most recently on 30 July 2025. 8 are listed as ongoing. Status and classification are as published by the FDA.

Recalls15
Ongoing (FDA)8
Terminated or completed7
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
30 July 2025
Reason
Due to a classification error in the inventory management system, specific medical devices were shipped to customers that did not have the requisite license to purchase such devices.
Distribution
US Nationwide distribution in the state of Georgia.
Initiated
Voluntary: Firm initiated
Recall number
Z-2337-2025

Ongoing Class II Drugs

Recall started
25 April 2025
Reason
Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.
Distribution
Distributed to Medical Facilities in MS and FL.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0401-2025, D-0400-2025

Ongoing Class II Medical devices

Recall started
24 April 2025
Reason
transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.
Distribution
US Nationwide distribution in the states of AL, AR, IL, KS, MT, NC, NJ, OR, SC, TN & WV.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1854-2025, Z-1846-2025, Z-1836-2025, Z-1837-2025, Z-1842-2025, Z-1851-2025, Z-1850-2025, Z-1843-2025, Z-1825-2025, Z-1855-2025, Z-1831-2025, Z-1840-2025 and 20 more

Ongoing Class II Drugs

Recall started
21 April 2025
Reason
CGMP Deviations; potential temperature excursions due to transit delays
Distribution
Within the U.S - OH, VA, FL.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0539-2025, D-0540-2025, D-0538-2025

Ongoing Class II Medical devices

Recall started
17 September 2024
Reason
The Quantimetrix Dipper Urinalysis Dipstick control was shipped without the validated summer packaging and may have been exposed to temperatures above 25¿C. This may lead to delay in patients' results.
Distribution
US Nationwide distribution in the state of DC.
Initiated
Voluntary: Firm initiated
Recall number
Z-0138-2025

Terminated Class II Drugs

Recall started
11 September 2024
Terminated
20 August 2025
Reason
cGMP Deviations: Temperature excursion
Distribution
Virgina
Initiated
Voluntary: Firm initiated
Recall number
D-0116-2025

Terminated Class II Drugs

Recall started
11 September 2024
Terminated
29 January 2025
Reason
Temperature abuse: Products exposed to improper temperature above drug label specifications.
Distribution
Product was distributed to two medical facilities in MD and VA.
Initiated
Voluntary: Firm initiated
Recall number
D-0661-2024

Completed Class II Medical devices

Recall started
23 April 2024
Reason
Quarantined product was inadvertently distributed
Distribution
US Nationwide distribution in the state of NJ.
Initiated
Voluntary: Firm initiated
Recall number
Z-2039-2024

Terminated Class II Drugs

Recall started
7 February 2024
Terminated
14 August 2024
Reason
cGMP Deviations: Products were stored outside the drug label specifications.
Distribution
Product was distributed to three direct accounts in NM, AZ and UT.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0373-2024, D-0371-2024, D-0372-2024

Ongoing Class II Medical devices

Recall started
9 January 2024
Reason
Facility Critical Temperature Excursions on 08-JAN 2024 in Walk-In refrigerator due to mechanical failures, causing temperatures to fall below the validated range of 35.6 - 46.4 Degrees Fahrenheit (2 - 8 Degrees Celsius) for up to 60 minutes which could increase the probability of an incorrect test result or a delayed test result.
Distribution
US Nationwide distribution in the states of AZ, PA and TX.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1313-2024, Z-1311-2024, Z-1314-2024, Z-1312-2024, Z-1315-2024

Terminated Class II Drugs

Recall started
29 June 2022
Terminated
13 February 2024
Reason
CGMP Deviations: products were stored outside the drug label specifications.
Distribution
Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall numbers
D-1317-2022, D-1321-2022, D-1319-2022, D-1325-2022, D-1320-2022, D-1324-2022, D-1323-2022, D-1327-2022, D-1315-2022, D-1311-2022, D-1313-2022, D-1312-2022 and 5 more

Ongoing Class II Medical devices

Recall started
25 May 2022
Reason
Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21.
Distribution
US Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1583-2022, Z-1636-2022, Z-1586-2022, Z-1615-2022, Z-1591-2022, Z-1596-2022, Z-1630-2022, Z-1629-2022, Z-1597-2022, Z-1620-2022, Z-1619-2022, Z-1599-2022 and 43 more

Ongoing Class III Medical devices

Recall started
25 May 2022
Reason
Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1791-2022, Z-1803-2022, Z-1787-2022, Z-1790-2022, Z-1789-2022, Z-1801-2022, Z-1796-2022, Z-1807-2022, Z-1802-2022, Z-1794-2022, Z-1793-2022, Z-1795-2022 and 11 more

Terminated Class II, Class III Drugs

Recall started
13 April 2022
Terminated
30 November 2023
Reason
cGMP deviations: Temperature abuse
Distribution
USA nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
D-1099-2022, D-1118-2022, D-1091-2022, D-1017-2022, D-1030-2022, D-1003-2022, D-1119-2022, D-1056-2022, D-1095-2022, D-1039-2022, D-1098-2022, D-1090-2022 and 118 more

Terminated Class II Medical devices

Recall started
2 June 2021
Terminated
28 April 2022
Reason
Two unsuitable 3mL syringes with conventional needles for vaccine administration included in some Moderna 140 Ancillary Convenience Kits.
Distribution
US Nationwide Distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-2081-2021

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.